发明名称 |
Method for protecting a retinal neuronal cell |
摘要 |
A method of protecting a retinal neuronal cell by administering an effective amount of a prostaglandin F2α derivative to a patient. A method of preventing or treating an eye disease associated with retinal neuronal cell damage by administering a therapeutically effective amount of a prostaglandin F2α derivative to a patient. |
申请公布号 |
US9138438(B2) |
申请公布日期 |
2015.09.22 |
申请号 |
US201113199598 |
申请日期 |
2011.09.02 |
申请人 |
ASAHI GLASS COMPANY, LIMITED;SANTEN PHARMACEUTICAL CO., LTD. |
发明人 |
Ishida Naruhiro;Shimazaki Atsushi |
分类号 |
A61K31/5575 |
主分类号 |
A61K31/5575 |
代理机构 |
Holtz, Holtz, Goodman & Chick PC |
代理人 |
Holtz, Holtz, Goodman & Chick PC |
主权项 |
1. A method for treating an eye disease selected from the group consisting of abnormal visual field, retinal vascular occlusion, diabetic retinopathy, ischemic optic neuropathy, macular degeneration, retinitis pigmentosa and Leber's disease, the method comprising administering to a patient in need thereof, wherein the patient does not have glaucoma, a therapeutically effective amount of a 15,15-difluoroprostaglandin F2α derivative is a compound represented by the following formula (1) or a salt thereof:wherein R represents a hydroxyalkyl group, a formyl group, a carboxy group, an isopropoxycarbonyl group, an alkoxycarbonyl group, an aryloxycarbonyl group, an aminocarbonyl group, an alkylaminocarbonyl group or an arylaminocarbonyl group, and when R is an aryloxycarbonyl group or an arylaminocarbonyl group, the aryl moiety thereof may have a substituent. |
地址 |
Tokyo JP |